
WHO Issues Alert Over ‘Fake’ Ozempic in UK Supply
The World Health Organization (WHO) has issued an alert after fake versions of the off-label weight-loss drug Ozempic were found to be in the supply chain of countries including the UK. Ozempic is a brand of a group of medications known as semaglutide, intended for type 2 diabetics, which have been repurposed as weight-loss drugs due to their ability to regulate blood sugar and reduce cravings, effectively suppressing appetite. Ozempic is not licensed as a weight loss drug on the NHS, but the so-called “skinny jabs” are easily obtainable privately in the UK for those looking to shift the pounds. The WHO said in a statement that it had detected three “falsified” batches of the drug in the United States, the UK, and Brazil in 2023, but the warning was only issued on June 20....
